This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tsoporis, J. Articles by Leenen, F. H. Search for Related Content PubMed PubMed Citation Articles by Tsoporis, J. Articles by Leenen, F. H. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB EPINEPHRINE HYDRALAZINE HYDROCHLORIDE MINOXIDIL

Hypertension, Vol 11, 376-386, Copyright © 1988 by American Heart Association

ARTICLES

Effects of arterial vasodilators on cardiac hypertrophy and sympathetic activity in rats

J Tsoporis and FH Leenen
Division of Clinical Pharmacology, Toronto Western Hospital, Ontario, Canada.

In spontaneously hypertensive rats (SHR), the progression (or absence of regression) of cardiac hypertrophy despite adequate blood pressure (BP) control by arterial vasodilators has been attributed to increased cardiac sympathetic activity. We evaluated changes in indices of general and cardiac sympathetic tone in relation to changes in cardiac anatomy during treatment of normotensive rats and SHR with hydralazine, 120 mg/L, or minoxidil, 120 mg/L of drinking water. In SHR, both vasodilators reduced BP rapidly and consistently. Significant increases in heart rate and plasma norepinephrine were observed only in the initial 2 days of arterial vasodilator treatment. After 5 weeks of treatment, marked increases in left and right ventricular sympathetic activity (as assessed by norepinephrine turnover rates) were present, but no increase was seen in heart rate and plasma norepinephrine. Intravascular volume expansion was observed on Day 14 of minoxidil and Day 35 of hydralazine treatment. Prolonged treatment with minoxidil induced significant increases in left ventricular internal diameter, as well as in left and right ventricular weights, but not in the wall thickness of the left ventricle. Treatment with hydralazine did not affect left ventricular weight and caused a small increase in the weight of the right ventricle. In normotensive rats, both vasodilators initially decreased BP, but tolerance developed within 1 to 2 weeks of treatment. Plasma norepinephrine and heart rate showed increases only at Day 1 of either treatment, whereas cardiac sympathetic hyperactivity persisted at 2 and 5 weeks of treatment. Changes in cardiac anatomy were qualitatively similar to those observed in SHR. We conclude that, during treatment of normotensive rats and SHR with arterial vasodilators, cardiac sympathetic hyperactivity persists and may be involved in the cardiac effects of arterial vasodilators. However, other mechanisms, such as chronic cardiac volume overload, may also play an important role, particularly with minoxidil.

This article has been cited by other articles:

				F. H. H. Leenen and B. Yuan Mortality After Coronary Artery Occlusion in Different Models of Cardiac Hypertrophy in Rats Hypertension, February 1, 2001; 37(2): 209 - 215. [Abstract] [Full Text] [PDF]

				P.A. van Zwieten The influence of antihypertensive drug treatment on the prevention and regression of left ventricular hypertrophy Cardiovasc Res, January 1, 2000; 45(1): 82 - 91. [Abstract] [Full Text] [PDF]

				A. Morimoto, T. Nishikimi, F. Yoshihara, T. Horio, N. Nagaya, H. Matsuo, K. Dohi, and K. Kangawa Ventricular Adrenomedullin Levels Correlate With the Extent of Cardiac Hypertrophy in Rats Hypertension, May 1, 1999; 33(5): 1146 - 1152. [Abstract] [Full Text] [PDF]

				G. F. Mitchell, M. A. Pfeffer, P. V. Finn, and J. M. Pfeffer Equipotent Antihypertensive Agents Variously Affect Pulsatile Hemodynamics and Regression of Cardiac Hypertrophy in Spontaneously Hypertensive Rats Circulation, December 1, 1996; 94(11): 2923 - 2929. [Abstract] [Full Text]

				I. M. Khan, K. L. Youngblood, M. P. Printz, T. L. Yaksh, and P. Taylor Spinal Nicotinic Receptor Expression in Spontaneously Hypertensive Rats Hypertension, December 1, 1996; 28(6): 1093 - 1099. [Abstract] [Full Text]

				H. Karam, D. Heudes, P. Bruneval, M.-F. Gonzales, B.-M. Loffler, M. Clozel, and J.-P. Clozel Endothelin Antagonism in End-Organ Damage of Spontaneously Hypertensive Rats: Comparison With Angiotensin-Converting Enzyme Inhibition and Calcium Antagonism Hypertension, September 1, 1996; 28(3): 379 - 385. [Abstract] [Full Text]

				M. Bohm, C. Grabel, M. Flesch, A. Knorr, and E. Erdmann Treatment in Hypertensive Cardiac Hypertrophy, II : Postreceptor Events Hypertension, May 1, 1995; 25(5): 962 - 970. [Abstract] [Full Text]

				M. J. Cox, H. S. Sood, M. J. Hunt, D. Chandler, J. R. Henegar, G. M. Aru, and S. C. Tyagi Apoptosis in the left ventricle of chronic volume overload causes endocardial endothelial dysfunction in rats Am J Physiol Heart Circ Physiol, April 1, 2002; 282(4): H1197 - H1205. [Abstract] [Full Text] [PDF]